140 related articles for article (PubMed ID: 27042072)
41. Increased Risk-Taking Behaviour and Brain-Derived Neurotrophic Factor Val66Met Polymorphism Correlates to Decreased Serum Brain-Derived Neurotrophic Factor Level in Heroin Users.
Roviš D; Černelič Bizjak M; Vasiljev Marchesi V; Petelin A; Jenuš T; Vidic S; Drevenšek G; Jenko Pražnikar Z
Eur Addict Res; 2018; 24(4):189-200. PubMed ID: 30134233
[TBL] [Abstract][Full Text] [Related]
42. Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers.
Ho BC; Milev P; O'Leary DS; Librant A; Andreasen NC; Wassink TH
Arch Gen Psychiatry; 2006 Jul; 63(7):731-40. PubMed ID: 16818862
[TBL] [Abstract][Full Text] [Related]
43. Association study of a brain-derived neurotrophic-factor polymorphism and short-term antidepressant response in major depressive disorders.
Lin E; Chen PS; Huang LC; Hsu SY
Pharmgenomics Pers Med; 2008; 1():1-6. PubMed ID: 23226029
[TBL] [Abstract][Full Text] [Related]
44. Association Between Brain-Derived Neurotrophic Factor Val66Met Polymorphism and Methamphetamine Use Disorder: A Meta-Analysis.
He L; Liao Y; Wu Q; Liu T
Front Psychiatry; 2020; 11():585852. PubMed ID: 33329128
[No Abstract] [Full Text] [Related]
45. Association studies of serotonin system candidate genes in early-onset obsessive-compulsive disorder.
Dickel DE; Veenstra-VanderWeele J; Bivens NC; Wu X; Fischer DJ; Van Etten-Lee M; Himle JA; Leventhal BL; Cook EH; Hanna GL
Biol Psychiatry; 2007 Feb; 61(3):322-9. PubMed ID: 17241828
[TBL] [Abstract][Full Text] [Related]
46. A benzisothiazole derivative and antipsychotic agent, perospirone, for augmentation of selective serotonin reuptake inhibitors (SSRIs) in refractory obsessive-compulsive disorder (OCD): two patient case series.
Matsunaga H; Matsui T; Ohya K; Okino K; Hayashida K; Maebayashi K; Kiriike N; Stein DJ
Int J Psychiatry Clin Pract; 2006; 10(2):142-5. PubMed ID: 24940965
[TBL] [Abstract][Full Text] [Related]
47. Association Between the Brain-derived Neurotrophic Factor Val66Met Polymorphism and Overweight/Obesity in Pediatric Population.
Martínez-Ezquerro JD; Rendón-Macías ME; Zamora-Mendoza G; Serrano-Meneses J; Rosales-Rodríguez B; Escalante-Bautista D; Rodríguez-Cruz M; Sánchez-González R; Arellano-Pineda Y; López-Alarcón M; Zampedri MC; Rosas-Vargas H
Arch Med Res; 2017 Oct; 48(7):599-608. PubMed ID: 29506764
[TBL] [Abstract][Full Text] [Related]
48. The interaction between Comt and Bdnf variants influences obsessive-compulsive-related dysfunctional beliefs.
Alonso P; López-Solà C; Gratacós M; Fullana MA; Segalàs C; Real E; Cardoner N; Soriano-Mas C; Harrison BJ; Estivill X; Menchón JM
J Anxiety Disord; 2013 Apr; 27(3):321-7. PubMed ID: 23602946
[TBL] [Abstract][Full Text] [Related]
49. BDNF VAL66MET Polymorphism Elevates the Risk of Bladder Cancer via MiRNA-146b in Micro-Vehicles.
Li C; Zeng X; Liu Z; Li F; Wang K; Wu B
Cell Physiol Biochem; 2018; 45(1):366-377. PubMed ID: 29402794
[TBL] [Abstract][Full Text] [Related]
50. Genetic Polymorphism of the Serotonin Transporter Gene, SLC6A4 rs16965628, Is Associated with Obsessive Compulsive Disorder.
Cengiz M; Okutan SN; Bayoglu B; Sakalli Kani A; Bayar R; Kocabasoglu N
Genet Test Mol Biomarkers; 2015 May; 19(5):228-34. PubMed ID: 25751280
[TBL] [Abstract][Full Text] [Related]
51. Antipsychotic treatment in obsessive-compulsive disorder: a literature review.
Keuneman RJ; Pokos V; Weerasundera R; Castle DJ
Aust N Z J Psychiatry; 2005 May; 39(5):336-43. PubMed ID: 15860020
[TBL] [Abstract][Full Text] [Related]
52. Association of the brain-derived neurotrophic factor Val66Met polymorphism with negative symptoms severity, but not cognitive function, in first-episode schizophrenia spectrum disorders.
Mezquida G; Penadés R; Cabrera B; Savulich G; Lobo A; González-Pinto A; Penzol MJ; Corripio I; Fernandez-Egea E; Gassó P; Cuesta MJ; Bernardo M;
Eur Psychiatry; 2016 Oct; 38():61-69. PubMed ID: 27668551
[TBL] [Abstract][Full Text] [Related]
53. Positive association between MET allele (BDNF Val66Met polymorphism) and obsessive-compulsive disorder.
Rocha FF; Malloy-Diniz L; Lage NV; Corrêa H
Braz J Psychiatry; 2010 Sep; 32(3):323-4. PubMed ID: 20945028
[No Abstract] [Full Text] [Related]
54. Val66Met polymorphism association with serum BDNF and inflammatory biomarkers in major depression.
Caldieraro MA; McKee M; Leistner-Segal S; Vares EA; Kubaski F; Spanemberg L; Brusius-Facchin AC; Fleck MP; Mischoulon D
World J Biol Psychiatry; 2018 Aug; 19(5):402-409. PubMed ID: 28656803
[TBL] [Abstract][Full Text] [Related]
55. Lack of association between BDNF Val66Met gene polymorphism and late-onset depression in a Chinese Han population.
You J; Yuan Y; Shi Y; Zhang Z; Zhang X; Li H
Acta Neuropsychiatr; 2009 Aug; 21(4):186-90. PubMed ID: 25384632
[TBL] [Abstract][Full Text] [Related]
56. The Met allele of BDNF Val66Met polymorphism is associated with increased BDNF levels in generalized anxiety disorder.
Moreira FP; Fabião JD; Bittencourt G; Wiener CD; Jansen K; Oses JP; Quevedo Lde Á; Souza LD; Crispim D; Portela LV; Pinheiro RT; Lara DR; Kaster MP; da Silva RA; Ghisleni G
Psychiatr Genet; 2015 Oct; 25(5):201-7. PubMed ID: 26110341
[TBL] [Abstract][Full Text] [Related]
57. An association between BDNF Val66Met polymorphism and impulsivity in methamphetamine abusers.
Su H; Tao J; Zhang J; Xie Y; Sun Y; Li L; Xu K; Han B; Lu Y; Sun H; Wei Y; Wang Y; Zhang Y; Zou S; Wu W; Zhang J; Zhang X; He J
Neurosci Lett; 2014 Oct; 582():16-20. PubMed ID: 25168604
[TBL] [Abstract][Full Text] [Related]
58. Brain-Derived Neurotrophic Factor Gene Val66Met Polymorphism and Risk of Schizophrenia: A Meta-analysis of Case-Control Studies.
Kheirollahi M; Kazemi E; Ashouri S
Cell Mol Neurobiol; 2016 Jan; 36(1):1-10. PubMed ID: 26134309
[TBL] [Abstract][Full Text] [Related]
59. The BDNF Val66Met polymorphism: relation to familiar risk of affective disorder, BDNF levels and salivary cortisol.
Vinberg M; Trajkovska V; Bennike B; Knorr U; Knudsen GM; Kessing LV
Psychoneuroendocrinology; 2009 Oct; 34(9):1380-9. PubMed ID: 19473771
[TBL] [Abstract][Full Text] [Related]
60. Cortisol and Brain-Derived Neurotrophic Factor Levels Prior to Treatment in Children With Obsessive-Compulsive Disorder.
Şimşek Ş; Gençoğlan S; Yüksel T; Kaplan İ; Alaca R
J Clin Psychiatry; 2016 Jul; 77(7):e855-9. PubMed ID: 27314567
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
